111 related articles for article (PubMed ID: 18635959)
1. Akt and mRNA translation by interferons.
Kaur S; Katsoulidis E; Platanias LC
Cell Cycle; 2008 Jul; 7(14):2112-6. PubMed ID: 18635959
[TBL] [Abstract][Full Text] [Related]
2. Role of the Akt pathway in mRNA translation of interferon-stimulated genes.
Kaur S; Sassano A; Dolniak B; Joshi S; Majchrzak-Kita B; Baker DP; Hay N; Fish EN; Platanias LC
Proc Natl Acad Sci U S A; 2008 Mar; 105(12):4808-13. PubMed ID: 18339807
[TBL] [Abstract][Full Text] [Related]
3. Growth suppressive cytokines and the AKT/mTOR pathway.
Kroczynska B; Kaur S; Platanias LC
Cytokine; 2009; 48(1-2):138-43. PubMed ID: 19682919
[TBL] [Abstract][Full Text] [Related]
4. The PI3' kinase pathway in interferon signaling.
Kaur S; Uddin S; Platanias LC
J Interferon Cytokine Res; 2005 Dec; 25(12):780-7. PubMed ID: 16375606
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of mRNA translation of interferon stimulated genes.
Joshi S; Kaur S; Kroczynska B; Platanias LC
Cytokine; 2010; 52(1-2):123-7. PubMed ID: 20409730
[TBL] [Abstract][Full Text] [Related]
6. Dual regulatory roles of phosphatidylinositol 3-kinase in IFN signaling.
Kaur S; Sassano A; Joseph AM; Majchrzak-Kita B; Eklund EA; Verma A; Brachmann SM; Fish EN; Platanias LC
J Immunol; 2008 Nov; 181(10):7316-23. PubMed ID: 18981154
[TBL] [Abstract][Full Text] [Related]
7. The p38 mitogen-activated protein kinase pathway and its role in interferon signaling.
Platanias LC
Pharmacol Ther; 2003 May; 98(2):129-42. PubMed ID: 12725866
[TBL] [Abstract][Full Text] [Related]
8. SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity.
Jacinto E; Facchinetti V; Liu D; Soto N; Wei S; Jung SY; Huang Q; Qin J; Su B
Cell; 2006 Oct; 127(1):125-37. PubMed ID: 16962653
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of the mammalian target of rapamycin signalling pathway in extramammary Paget's disease.
Chen S; Nakahara T; Uchi H; Takeuchi S; Takahara M; Kido M; Dugu L; Tu Y; Moroi Y; Furue M
Br J Dermatol; 2009 Aug; 161(2):357-63. PubMed ID: 19438435
[TBL] [Abstract][Full Text] [Related]
10. Interferon receptor signaling in malignancy: a network of cellular pathways defining biological outcomes.
Fish EN; Platanias LC
Mol Cancer Res; 2014 Dec; 12(12):1691-703. PubMed ID: 25217450
[TBL] [Abstract][Full Text] [Related]
11. Novel Gemini-vitamin D3 analog inhibits tumor cell growth and modulates the Akt/mTOR signaling pathway.
O'Kelly J; Uskokovic M; Lemp N; Vadgama J; Koeffler HP
J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):107-16. PubMed ID: 16777406
[TBL] [Abstract][Full Text] [Related]
12. Interferons activate the p42/44 mitogen-activated protein kinase and JAK-STAT (Janus kinase-signal transducer and activator transcription factor) signalling pathways in hepatocytes: differential regulation by acute ethanol via a protein kinase C-dependent mechanism.
Nguyen VA; Chen J; Hong F; Ishac EJ; Gao B
Biochem J; 2000 Jul; 349(Pt 2):427-34. PubMed ID: 10880341
[TBL] [Abstract][Full Text] [Related]
13. Signaling pathways activated by interferons.
Platanias LC; Fish EN
Exp Hematol; 1999 Nov; 27(11):1583-92. PubMed ID: 10560905
[TBL] [Abstract][Full Text] [Related]
14. Interferons: mechanisms of action and clinical applications.
Parmar S; Platanias LC
Curr Opin Oncol; 2003 Nov; 15(6):431-9. PubMed ID: 14624225
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori promotes eukaryotic protein translation by activating phosphatidylinositol 3 kinase/mTOR.
Sokolova O; Vieth M; Gnad T; Bozko PM; Naumann M
Int J Biochem Cell Biol; 2014 Oct; 55():157-63. PubMed ID: 25194338
[TBL] [Abstract][Full Text] [Related]
16. PI3K-Akt-mTOR axis sustains rotavirus infection via the 4E-BP1 mediated autophagy pathway and represents an antiviral target.
Yin Y; Dang W; Zhou X; Xu L; Wang W; Cao W; Chen S; Su J; Cai X; Xiao S; Peppelenbosch MP; Pan Q
Virulence; 2018 Jan; 9(1):83-98. PubMed ID: 28475412
[TBL] [Abstract][Full Text] [Related]
17. Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size.
Trendelenburg AU; Meyer A; Rohner D; Boyle J; Hatakeyama S; Glass DJ
Am J Physiol Cell Physiol; 2009 Jun; 296(6):C1258-70. PubMed ID: 19357233
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of type I interferon signaling in normal and malignant cells.
Li Y; Srivastava KK; Platanias LC
Arch Immunol Ther Exp (Warsz); 2004; 52(3):156-63. PubMed ID: 15247882
[TBL] [Abstract][Full Text] [Related]
19. ASCT2 silencing regulates mammalian target-of-rapamycin growth and survival signaling in human hepatoma cells.
Fuchs BC; Finger RE; Onan MC; Bode BP
Am J Physiol Cell Physiol; 2007 Jul; 293(1):C55-63. PubMed ID: 17329400
[TBL] [Abstract][Full Text] [Related]
20. AKT inhibition overcomes rapamycin resistance by enhancing the repressive function of PRAS40 on mTORC1/4E-BP1 axis.
Mi W; Ye Q; Liu S; She QB
Oncotarget; 2015 Jun; 6(16):13962-77. PubMed ID: 25961827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
